Drug Trial Radar · NCT04244084
Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection
Last checked: Nov 19, 2026Latest source record: May 17, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
240
Actual
Start
Oct 8, 2019
Primary completion
Apr 9, 2020
Study completion Apr 9, 2020
Sponsor
- Lead sponsor
- Materia Medica HoldingIndustry
- Sponsor type
- Industry
- First posted
- Jan 28, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy and safety of ММН-407 in treatment of acute respiratory viral infection (ARVI).
Conditions
- Viral Respiratory Infection
Interventions
MMH-407Drug
Oral use.
PlaceboDrug
Oral use.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Resolution of Acute Respiratory Viral Infection (ARVI) SymptomsTime frame: 14 days of observation.
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
Altai State Medical University, Department of Faculty Therapy with a course of immunology and allergology
Barnaul, Russia
City Hospital #5
Barnaul, Russia
Belgorod State National Research University, Hospital Therapy Department
Belgorod, Russia
Road Clinical Hospital at Chelyabinsk station of JSC Russian Railways
Chelyabinsk, Russia
City Clinical Hospital #9 of the Ministry of Health of the Udmurt Republic
Izhevsk, Russia
Kazan State Medical University, Internal Medicine Department
Kazan', Russia
Kazan State Medical University, Professorial clinic
Kazan', Russia
Kuban State Medical University, Infectious Diseases and PhthisiopulmonologyDepartment
Krasnodar, Russia
Central Clinical Hospital of the Russian Academy of Sciences
Moscow, Russia
Moscow State Medical and Dental University named after A.I. Evdokimov, Pulmonology Laboratory
Moscow, Russia
City Clinical Hospital #10 of the Kanavinsky District of Nizhny Novgorod
Nizhny Novgorod, Russia
Road Clinical Hospital at the station Nizhny Novgorod of JSC Russian Railways
Nizhny Novgorod, Russia
Podolsk City Clinical Hospital # 3
Podolsk, Russia
City Emergency Hospital Rostov-on-Don
Rostov-on-Don, Russia
Ryazan State Medical University named after academician I.P. Pavlov, Department of Outpatient Therapy and Preventive Medicine
Ryazan, Russia
Vvedensky City Clinical Hospital
Saint Petersburg, Russia
City Polyclinic #25 of the Nevsky District
Saint Petersburg, Russia
Medical Center "Reavita Med SPb"
Saint Petersburg, Russia
Road Clinical Hospital of JSC Russian Railways
Saint Petersburg, Russia
City Polyclinic #51
Saint Petersburg, Russia
City Polyclinic #34
Saint Petersburg, Russia
City Polyclinic #43
Saint Petersburg, Russia
Samara City Hospital #4
Samara, Russia
Scientific Medical Center for General Therapy and Pharmacology
Stavropol, Russia
Bashkir State Medical University, Internal Medicine Department
Ufa, Russia
Volgograd State Medical University
Volgograd, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.